Foluso Ogunleye, MD, Oncology, Las Vegas, NV, HonorHealth John C. Lincoln Medical Center


Oncology Las Vegas, NV

Hematologic Oncology


Dr. Ogunleye is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ogunleye's full profile

Already have an account?


  • Dr. Foluso Ogunleye is an oncologist at the Optumcare Cancer Center, in Las Vegas, NV and is affiliated with multiple hospitals in the area, including UMC, Saint Rose Dignity hospitals, Southern Hill Hospital, Mountain View Hospital, Sunrise Hospital, and the Valley Hospitals system. He received his medical degree from University of Benin Faculty of Medicine and has been in practice 16 years. He specializes in hematologic oncology and is experienced in neuro-oncology, amyloidosis, hematologic oncology, breast cancer, and prostate cancer.

Education & Training

  • William Beaumont Hospital
    William Beaumont HospitalFELLOWSHIP
  • Roger Williams HospitalRESIDENCY
  • University of Benin  Faculty of Medicine
    University of Benin Faculty of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • NV State Medical License
    NV State Medical License 2019 - 2021
  • CA State Medical License
    CA State Medical License 2018 - 2020
  • AZ State Medical License
    AZ State Medical License 2017 - 2021
  • MI State Medical License
    MI State Medical License 2014 - 2018
  • GA State Medical License
    GA State Medical License 2011 - 2016
  • IA State Medical License
    IA State Medical License 2008 - 2013
  • IL State Medical License
    IL State Medical License 2006 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Publications & Presentations


Journal Articles

  • Ibrutinib as a Bruton's Tyrosine Kinase Inhibitor in the management of Chronic Lymphocytic Lymphoma  
    Ogunleye Foluso, MD Alexander Glick, MD Michael Stender, MD Ishmael Jaiyesimi, DO, Clinical lymphoma Myeloma and Leukemia
  • Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advance Non-Small Cell Lung Cancer. A paradigm shift in Stage IV NSCLC treatment  
    Foluso Ogunleye, MD Mohammed Ibrahim, MD Michael Stender, MD Gregory Kalemkeriam, MD Ishmael Jaiyesimi DO, American Journal of Hematology/Oncology, 1/16/2015


  • Programmed cell death-1/Programmed cell death ligand-1(PD-1/PD-L1) inhibitors, heralding a new era of immunotherapy in the management of advanced Non-Small Cell Lung C...
    Foluso Ogunleye, LeAnn Blankenship, Vanessa Millisor, Joseph Anderson, Ishmael Jaiyesimi, ancer Treatment and Research Communications, Volume 12, 2017, Pages 6-13, ISSN 2468-2942,, 5/2/2017
  • Treatment patterns for resected gastric cancer using the National Cancer Database.
    Foluso Nelson Ogunleye, Karna Tushar Sura, Leann Blankenship, Daniel Ezekwudo, Bolanle Gbadamosi, Ishmael A. Jaiyesimi, and Peyman Kabolizadeh, Journal of Clinical Oncology 2017 35:15_suppl, 4061-4061, 5/1/2017


  • Member, Clinical trial review committee Rose Cancer Treatment Center 2015 - 2016

Professional Memberships

Hospital Affiliations